FDA Announced Recall of Two Different Thyroid Medications


Westminster Pharmaceuticals announced recall of two thyroid medications, levothyroxine and liothyronine, along with the Food and Drug Administration (FDA), according to a report published on August 15, 2018.

Although no illness or problems have been reported about the medication, these tablets that are used for the treatment of hypothyroidism are being recalled, as these tablets might contain adulterants or contaminants. Many aspects of metabolism such as how fast your heart beats, how quickly you burn calories, and your level of energy and fatigue can be controlled by the thyroid gland.

Hypothyroidism is a condition in which lower-than-normal levels of thyroid hormones are produced, which can lead to weight gain, fatigue, feeling cold, constipation, joint pain, depression, dry skin, and heavier periods. This is most commonly seen in women than men and five out of every 100 people in the U.S. suffer from hypothyroidism.

These medications are being recalled, as it contain ingredients sourced from Sichuan Friendly Pharmaceutical in China, which was cited in June for not meeting the strict manufacturing guidelines required by the FDA. The manufacturers of drugs need to document the testing and procedures that are used for ensuring the quality of the medications.

FDA said in a statement, “Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product.” The drugs were sold wholesale in 100-count bottles in 15-, 30-, 60-, 90-, and 120-mg doses, with expiration dates in 2019 and 2020. The company is reaching out to wholesalers to return the medication.